Real-time enrollment status for this gastroenteropancreatic neuroendocrine tumor clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 2:50 AM UTC
| NCT Number | NCT04609592 |
| Recruiting Status | Recruiting |
| Condition | Gastroenteropancreatic Neuroendocrine Tumor |
| Phase | PHASE1 |
| Target Enrollment | 10 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Stanford University |
| Last Updated on CT.gov | September 9, 2025 (Sep 9, 2025) |
As of July 20, 2026: Clinical trial NCT04609592 is currently recruiting participants. This phase1 study for gastroenteropancreatic neuroendocrine tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by Stanford University. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04609592 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04609592 was last updated Sep 9, 2025 (September 9, 2025). HelloStudys verifies this status automatically.